Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is required. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosev, Georgi, Wahafu, Wasilijiang, Reimold, Philipp, Damgov, Ivan, Schwab, Constantin, Aksoy, Cem, Kaczorowski, Adam, Stenzinger, Albrecht, Nyarangi-Dix, Joanne, Hohenfellner, Markus, Duensing, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270894/
https://www.ncbi.nlm.nih.gov/pubmed/34244564
http://dx.doi.org/10.1038/s41598-021-93754-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270894/
https://www.ncbi.nlm.nih.gov/pubmed/34244564
http://dx.doi.org/10.1038/s41598-021-93754-z

Ejemplares similares